Objectives-Ductal carcinoma in situ (DCIS) represents 20%-25% of malignancy detected at mammographic screening. This study aims to clarify the value of detecting DCIS at mammographic screening by assessing its biological characteristics and by comparing screen detected DCIS with a series of symptomatic DCIS lesions. Methods-222 Screen detected and 151 symptomatic cases of pure DCIS were identified. Their histological grade and the prevalence of necrosis were ascertained and compared.
The introduction of mammographic screening has led to an increase in the number of cases of pure ductal carcinoma in situ (DCIS) diagnosed. Of screen detected breast cancers, 20%-25% 1 are DCIS compared with 5% of symptomatic breast cancer. 2 Screening women under 50 years of age is associated with even higher proportions of pure DCIS lesions than those found when screening women over 50. 3 Ductal carcinoma represents a range of disease. Low grade DCIS has only a 25%-50% chance of developing into low grade invasive cancer at 30 years 4 and has low rates of local recurrence when treated by wide local excision. 5 High grade DCIS that is often associated with necrosis, in one small series had a 75% risk of invasive disease with a mean time to recurrence of only 4 years. 6 A more recent study has shown that DCIS with poorly diVerentiated cytonuclear morphology has a significantly higher risk for the development of invasive carcinoma than DCIS with well diVerentiated cytonuclear appearance. 7 High grade DCIS is associated with high grade invasive cancer. [8] [9] [10] High grade invasive cancer carries a poor prognosis 11 unless detected when less than 10 mm in size. 12 High histological grade DCIS and the presence of necrosis are known to predict higher rates of recurrence after treatment by wide local excision. 13 14 About 50% of recurrent lesions after wide local excision of DCIS have invasive carcinoma and there is a strong association between the grade of the original lesion and the grade of the recurrent invasive carcinoma.
Critics of breast screening often claim that the high rates of DCIS found represent overdiagnosis, many being lesions which would never present clinically and threaten the woman's life. 15 Such lesions are also often extensive 16 and therefore often require mastectomy to obtain adequate excision. Such criticism would be valid if screen detected DCIS lesions were predominantly of low histological grade but would not be valid if screen detected DCIS was predominantly of high histological grade. The detection of high grade DCIS by screening is likely to prevent the development of high grade invasive cancer of poor prognosis, within a few years and could be important in producing part of the reduction in mortality found in randomised trials of mammographic screening.
Very few, if any, clinicians think that they should not treat symptomatic DCIS. We therefore aim to compare the biological characteristics of screen detected DCIS with those of symptomatic DCIS and allow the doubt that exists concerning the benefit of detecting DCIS at screening to be seen within this context. This study aims to clarify the value of detecting DCIS at mammographic screening by assessing its histological grade and the prevalence of necrosis and by comparing screen detected DCIS with a series of symptomatic DCIS lesions.
Methods
All cases of DCIS diagnosed at our institution since 1973 have had their pathological details recorded on a database. Each case was investigated to see if the lesion was screen detected or was symptomatic. This was normally done by consulting the breast screening computer system and looking at the clinical information given on diagnostic breast imaging reports from the time of diagnosis (AJE). Lesions picked up on opposite breast follow up mammography, family history screening, or lesions found on symptomatic mammography for symptoms in the other breast were also classified as screen detected. Population mammographic screening began in our unit in 1987.
The symptomatic lesions were detected in women with nipple discharge, Paget's disease, or breast lumps. In our institution single duct nipple discharge is investigated by mammography and nipple discharge cytology. If either of these is suggestive of malignancy either percutaneous or surgical biopsy is performed. Galactography is not used at our institution.
All cases underwent pathological review to ascertain histological grade 17 and the presence or absence of necrosis. The grade and incidence of necrosis in DCIS cases that were symptomatic and screen detected were compared and statistical significance was ascertained with the 2 test and 2 test for trend.
Results
Two hundred and twenty two screen detected (age 37-74, mean 58 years) and 151 symptomatic (age 30-82, mean 54 years) cases of pure DCIS were identified. Ductal carcinoma in situ represented 20% of screen detected cancers during the study period and was detected at a rate of 1.2/1000 women screened. The detection rate of screen detected invasive cancer during this period was 4.6/1000. Over the study period DCIS represented 4% of symptomatic breast cancer.
Of the screen detected lesions 28 (13%) were low grade, 40 (18%) intermediate grade, and 153 (69%) high grade. One case was not graded. Of screen detected lesions 186 (87%) were necrotic and 29 (13%) were not. In seven the presence or absence of necrosis was not known.
Of the 151 symptomatic lesions 24 (16%) were low grade, 34 (23%) intermediate grade, and 89 (61%) high grade. Four cases were not graded. Of symptomatic lesions 112 (76%) were necrotic and 36 (24%) were not necrotic. The presence or absence of necrosis was unknown in three.
No significant diVerence was found between the grade of screen detected and symptomatic DCIS (p=0.08). Screen detected DCIS was more often necrotic (p=0.008) than symptomatic DCIS.
Discussion
Long term studies on the progression to invasive disease of DCIS lesions originally misdiagnosed as benign indicate a 25%-50% rate of invasive disease at 30 years of follow up. 4 These studies consist almost entirely of low grade DCIS lesions, as such lesions are more likely to be misdiagnosed as benign lesions than high grade DCIS. Data on the natural history of high grade DCIS is limited but a small series showed a 75% rate of progression to invasive disease with a mean time to progression of 4 years. 6 A more recent study has shown that DCIS with poorly diVerentiated cytonuclear morphology has a significantly higher risk for the development of invasive carcinoma than DCIS with well diVerentiated cytonuclear morphology. 7 Evidence from recurrence after breast conserving surgery for DCIS indicate that high grade DCIS and DCIS with necrosis represent a biologically aggressive subset of DCIS which show higher rates of invasive and in situ recurrence compared with low grade DCIS lesions without necrosis. 5 13 14 18 Invasive lesions with an extensive intraductal component show a predisposition to local recurrence after breast conserving therapy. 19 The grade of DCIS associated with invasive cancers has been shown to correlate with both disease free interval and survival. 8 These data indicate the biological importance of DCIS and show that the grade of associated DCIS has biological relevance. The strong associations that exist between the grade of invasive cancers and the grade of DCIS from which they arose may at least in part explain these associations. High grade DCIS gives rise to high grade invasive cancer whereas low grade DCIS gives rise to low grade invasive cancer. [8] [9] [10] The association between grade 3 invasive cancer and poorly diVerentiated DCIS is present whatever grading system is used. On average, with five diVerent grading systems, 67% of invasive cancers associated with high grade DCIS were grade 3. 10 With the Van Nuys system as many as 75% of invasive cancers associated with high grade DCIS are grade 3.
Necrosis represents another marker of DCIS lesions with aggressive biological characteristics. Ductal carcinoma in situ with necrosis has been shown to have a poorer disease free survival and a higher local recurrence rate than DCIS without necrosis: 5 16 DCIS with necrosis has also been shown to be associated with microinvasion.
Previous studies that have compared the histological features of screen detected and symptomatic DCIS used DCIS classifications based on architectural pattern. 20 21 These studies found that comedo DCIS was commoner in screen detected lesions than in lesions presenting symptomatically. 20 21 Since these studies were published several new DCIS classifications have been proposed based on cytological features and the presence of necrosis. 5 17 22 23 These classifications have become accepted as being more reproducable and being more accurate in predicting the biological behaviour of DCIS lesions.
This study has shown that DCIS detected by mammographic screening is predominantly of high nuclear grade and only 13% is low grade. Screen detected DCIS is also more likely to contain areas of necrosis than symptomatic lesions. The most likely explanation for these findings is suggested by a comparison of the radiological findings of diVerent DCIS subtypes. High grade DCIS more often shows abnormal mammographic features than low grade DCIS, which is often mammographically occult. 16 24 The mammographic calcification found in high grade DCIS and DCIS with necrosis is more characteristic of malignancy, often showing rod and branch shapes. The granular-punctate calcifications found in low grade DCIS 24 are non-specific and are more likely to be confused with benign processes and not recalled at mammographic screening.
The subtype profile of screen detected DCIS suggests that most lesions would progress to high grade invasive disease within 5-10 years. Preventing such high grade invasive disease is likely to have a considerable impact on breast cancer mortality. The small proportion of low grade, non-necrotic DCIS lesions found at mammographic screening indicates that diagnosis of the more indolent forms of DCIS is not common. This finding indicates that overdiagnosis of DCIS at mammographic screening is not a major problem.
On the basis of this evidence we advocate that the aggressive investigation of suspicious microcalcification at mammographic screening should be encouraged. The consequent detection of predominantly high grade DCIS at screening also enables the diagnosis of otherwise occult coexisting small grade 3 invasive carcinomas, which have already arisen within the DCIS lesions. 25 The increased availability of stereotactic core biopsy, especially with digital imaging, has led to good diagnostic results when sampling mammographic calcifications. [26] [27] [28] This should mean that an aggressive approach to mammographic calcification should not give rise high rates of surgical benign biopsy. Given the nature of screen detected DCIS, the existence of an upper limit for the detection of DCIS by the NHS breast screening programme seems to be inappropriate. 29 
